The Global Nuclear Medicine Diagnostics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc.
According to the report the Nuclear Medicine Diagnostics Market is estimated to be USD 12.6 billion in 2020 and predicted to rise to USD 23.42 billion by 2025, with a CAGR of 13.2%. The market is segmented by SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others), PET (Rubidium-82 (RB-82), Fluorine-18, and others), and applications SPECT (lymphoma, cardiology, neurology, thyroid, and others) and PET (cardiology, oncology, neurology, and others). Further, the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America, and Middle-East & Africa
Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are the major factors driving the growth of the market. However, the short half-life of radioisotopes, stringent regulatory guidelines, and reimbursement issues are the major restraints for the growth of the nuclear medicine diagnostics market.
North America is the largest market for Nuclear Medicine Diagnostics Market owing to the increasing preference for SPECT and PET scans. Asia-Pacific is estimated to be the fastest-growing market due to the increasing count of individuals suffering from cancer and cardiac ailments during the forecast period.
The major companies covered in the report are Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.
Browse full details of the report @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market
Avail Sample Brochure of the report @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market/request-sample